Immediate Impact

60 hit
Sub-graph 1 of 24

Citing Papers

A comprehensive review of methodologies and application to use the real-world data and analytics platform TriNetX
2025 Hit
Customizable virus-like particles deliver CRISPR–Cas9 ribonucleoprotein for effective ocular neovascular and Huntington’s disease gene therapy
2025 Hit
2 intermediate papers

Works of Michael N. Cohen being referenced

Racial, Ethnic, and Gender Disparities in Diabetic Macular Edema Clinical Trials
2022
APEX: a phase II randomised clinical trial evaluating the safety and preliminary efficacy of oral X-82 to treat exudative age-related macular degeneration
2020

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Michael N. Cohen 200 130 90 43 36 45 388
Rinat M. Zainullin 227 1.1× 166 1.3× 13 0.1× 31 0.7× 10 0.3× 45 421
Giancarlo Sborgia 197 1.0× 179 1.4× 37 0.4× 33 0.8× 11 0.3× 57 386
J. Katsimpris 332 1.7× 200 1.5× 24 0.3× 38 0.9× 24 0.7× 37 420
Fabio Cruciani 139 0.7× 77 0.6× 55 0.6× 41 1.0× 45 1.3× 41 433
Peyman Roomizadeh 52 0.3× 115 0.9× 27 0.3× 14 0.3× 132 3.7× 21 380
Mingxu Wang 144 0.7× 94 0.7× 15 0.2× 85 2.0× 30 0.8× 32 399
Dilya F. Yakupova 195 1.0× 144 1.1× 15 0.2× 17 0.4× 8 0.2× 23 352
Turgay Ulaş 34 0.2× 45 0.3× 38 0.4× 35 0.8× 63 1.8× 37 390
Zeki Bayraktar 107 0.5× 57 0.4× 57 0.6× 49 1.1× 68 1.9× 31 387
Qiuyue Tian 55 0.3× 62 0.5× 16 0.2× 86 2.0× 32 0.9× 38 407

All Works

Loading papers...

Rankless by CCL
2026